METTL3/YTHDF2 m6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer
Haiyun Xie1, Jiangfeng Li1, Yufan Ying1
1Department of Urology, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Abstract:
N6-Methyladenosine (m6 A) modification, the most prevalent modification of eukaryotic messenger RNA (mRNA), is involved in the progression of various tumours. However, the specific role of m6 A in bladder cancer (BCa) is still poorly understood. In this study, we demonstrated the tumour-promoting function and specific regulatory mechanism of m6 A axis, consisting of the core 'writer' protein METTL3 and the major reader protein YTHDF2. Depletion of METTL3 impaired cancer proliferation and cancer metastasis in vitro and in vivo. Through transcriptome sequencing, m6 A methylated RNA immunoprecipitation (MeRIP) and RIP, we determined that the METTL3/YTHDF2 m6 A axis directly degraded the mRNAs of the tumour suppressors SETD7 and KLF4, contributing to the progression of BCa. In addition, overexpression of SETD7 and KLF4 revealed a phenotype consistent with that induced by depletion of the m6 A axis. Thus, our findings on the METTL3/YTHDF2/SETD7/KLF4 m6 A axis provide the insight into the underlying mechanism of carcinogenesis and highlight potential therapeutic targets for BCa.
Insights
N6-Methyladenosine (m6A) RNA modification promotes bladder cancer (BCa) by degrading tumor suppressor mRNAs. Targeting the METTL3/YTHDF2 axis could offer new therapeutic strategies for BCa treatment.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- N6-Methyladenosine (m6A) is the most common mRNA modification in eukaryotes.
- m6A modification plays a role in various cancers, but its specific function in bladder cancer (BCa) remains unclear.
Purpose of the Study:
- To investigate the role and mechanism of the m6A axis in bladder cancer progression.
- To identify potential therapeutic targets for BCa.
Main Methods:
- Depletion of METTL3 in vitro and in vivo.
- Transcriptome sequencing.
- m6A methylated RNA immunoprecipitation (MeRIP) and RIP assays.
- Overexpression of SETD7 and KLF4.
Main Results:
- METTL3 depletion inhibited BCa proliferation and metastasis.
- The METTL3/YTHDF2 m6A axis was found to directly degrade the mRNAs of tumor suppressors SETD7 and KLF4.
- Restoring SETD7 and KLF4 levels mimicked the effects of depleting the m6A axis.
Conclusions:
- The METTL3/YTHDF2/SETD7/KLF4 m6A axis promotes bladder cancer progression.
- This axis represents a potential therapeutic target for BCa.
More Related Videos
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Abnormal Proliferation
The Tumor Microenvironment
Destabilization of Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
